$TG治疗(TGTX)$ 真惨，话说Ublituximab的中国权益，恒瑞还拥有优先出价权。。。
FDA will convene an adcomm ahead of the biotech’s upcoming PDUFA date for a blood cancer combo therapy, throwing a potential decision into limbo.
| 发布于: | 雪球 | 转发：0 | 回复：0 | 喜欢：0 |
$TG治疗(TGTX)$ 真惨，话说Ublituximab的中国权益，恒瑞还拥有优先出价权。。。
FDA will convene an adcomm ahead of the biotech’s upcoming PDUFA date for a blood cancer combo therapy, throwing a potential decision into limbo.